
Lemonaid Health, now part of 23andMe, is a national telehealth company founded in 2013 with the mission to make healthcare more convenient and affordable for Americans. They offer on-demand telehealth services and a healthcare platform focused on prevention and wellness, powered by genetic and non-genetic data. Lemonaid Health provides a wide range of services including weight loss, mental health, men's health, women's health, general health, and skin treatments, with a medical team licensed in all 50 states. They emphasize a patient-obsessed, mission-driven approach, aiming to break down barriers to quality healthcare.

Lemonaid Health, now part of 23andMe, is a national telehealth company founded in 2013 with the mission to make healthcare more convenient and affordable for Americans. They offer on-demand telehealth services and a healthcare platform focused on prevention and wellness, powered by genetic and non-genetic data. Lemonaid Health provides a wide range of services including weight loss, mental health, men's health, women's health, general health, and skin treatments, with a medical team licensed in all 50 states. They emphasize a patient-obsessed, mission-driven approach, aiming to break down barriers to quality healthcare.
Founded: 2013
Business: U.S. telemedicine platform offering virtual primary/urgent care and an online pharmacy
Acquisition: Acquired by 23andMe (reported 2021)
Recent disclosed round: $33M Series B (Jul 31, 2020)
Access and affordability gaps in primary and urgent care through digital telemedicine and online pharmacy services.
2013
Telemedicine / Digital Health
$33,000,000
Reported oversubscribed Series B; reporting indicates prior Series A in 2017 and total financing before acquisition of roughly $55M.
“Lead investor on Series B reported as OTV (Olive Tree Ventures); other participating investors reported include Sierra Ventures, Artis Ventures, Correlation Ventures, Hikma Ventures, Health Velocity Capital and Endurance Companies.”